Loading stock data…
Bluejay Diagnostics (BJDX)
$1.44-1.49 (-50.85%)
Market ClosedLast close Jun 29
Bluejay Diagnostics, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bluejay Diagnostics, Inc. in the Healthcare sector is trading at $1.44 with a market capitalization of $5M. The stock is currently near its 52-week low of $1.13, remaining 64.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 14 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 14) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.94M↓ | -$1.46M↑ | -$1.62M↑ | -$1.99M↓ | -$1.89M |
| Net Income | -$1.92M↓ | -$1.43M↑ | -$1.60M↑ | -$1.96M↓ | -$1.86M |
Peer Comparison
JNJUNHPFE
Fundamentals
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarke...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.97M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-165.10%
Volume
Today's trading volume
2.69M
Recent News
Traders Digest Earnings, Powell Speech, Driving Muted Premarket Action for US Equity Futures
US equity futures were flat ahead of Thursday's opening bell as traders digested earnings from Pepsi
BC-Most Active Stocks
Gibo Holdings Ltd. 239,477,124 0.049